Parkinson ' s disease . Clinical and [ 18 F ] dopa PET findings in early

Twenty seven patients with recent onset (mean symptom duration 22 (SD 14) months, Hoehn and Yahr score 1-8 (SD 0.7)) Parkinson's disease were studied with ['8F]dopa PET. There was a correlation between putamen influx (Ki) and clinical rating, but not symptom duration. In 11 patients with hemi-Parkinson's disease of recent onset there were significant differences between normal (mean 0-0123 (SD 0.0023)), asymptomatic (mean 0 0099 (0.0020)) and symptomatic (mean 0*0070 (00.014)) putamen Kis. This suggests that Parkinson's disease has a widely variable rate of progression, and is most compatible with a short preclinical period. Symptom onset was estimated at a putamen Ki of between 57% and 80% of normal. Most ipsilateral putamen Ki values in early asymmetric Parkinson's disease fell within the normal range. The implication is that either the disease is not established in the ipsilateral putamen or that the technique is insufficiently sensitive to detect it. Discriminant analysis completely separated the normal and Parkinson's disease cohorts, but when a discriminant function from a previous study was used predictively four of the 27 patients with Parkinson's disease were incorrectly classified as normal. Cyclotron Unit, Hammersmith Hospital, DuCane Road, London W12 OHS, UK P K Morrish, D J Brooks Institute ofNeurology, Queen Square, London WCIN 3BG, UK D J Brooks Division of Clinical Neurology, Department of Medicine, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK G V Sawle Correspondence to: Dr P K Morrish, MRC Cyclotron Unit, Hammersmith Hospital, DuCane Road, London W12 OHS, UK. Received 9 May 1995 and in revised form 25 July 1995 Accepted 2 August 1995 (7 Neurol Neurosurg Psychiatry 1995;59:597-600)

[1]  R A Robb,et al.  A software system for interactive and quantitative visualization of multidimensional biomedical images. , 1991, Australasian physical & engineering sciences in medicine.

[2]  Wade K. Smith,et al.  Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.

[3]  C D Marsden,et al.  The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. , 1990, Brain : a journal of neurology.

[4]  S. Goto,et al.  Subdivisional involvement of nigrostriatal loop in idiopathic parkinson's disease and striatonigral degeneration , 1989, Annals of neurology.

[5]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[6]  A. E. Harding,et al.  Parkinson's disease in twins studied with 18F‐dopa and positron emission tomography , 1992, Neurology.

[7]  J. Langston,et al.  Does a long preclinical period occur in Parkinson's disease? , 1991, Neurology.

[8]  G. Sawle,et al.  Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data. , 1994, Archives of neurology.

[9]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[10]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  V. Dhawan,et al.  Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[13]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[14]  C. Patlak,et al.  Striatal 18F-DOPA Uptake: Absence of an Aging Effect , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Richard S. J. Frackowiak,et al.  Striatal function in normal aging: Implications for Parkinson's disease , 1990, Annals of neurology.

[16]  D J Brooks,et al.  Detection of preclinical Parkinson's disease with PET , 1991, Neurology.

[17]  D B Calne,et al.  Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices , 1993, Annals of neurology.

[18]  H. Kimura,et al.  Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.

[19]  K. Jellinger,et al.  The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease , 1991, Journal of neuropathology and experimental neurology.

[20]  R. Schwab,et al.  Progression of unilateral tremor and rigidity in Parkinson's disease , 1970, Neurology.